FDA-Approved Treatment Option | Selective KRAS G12C Inhibitor
Sponsored Learn More About An Oral Treatment Option For Your Patients With KRAS G12C-Mutate…Official HCP Site · Support For Patients · Dosing Info · Clinical Data
For HCPs: B7-H3 In Oncology | Cancer Cell Pathways And B7-H3
Sponsored For HCPs: Explore The Prevalence Of B7-H3 Expression And Its Role In Antitumor Immun…Types: Tumor Cell Activation, B7-H3 Expression, Pro-tumorigenic Effects
